Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,088.94
(
-0.52%
)
US TECH 100
25,732.71
(
-0.85%
)
Dow Jones
49,313.82
(
-0.27%
)
Brent Oil
92.17
(
-0.53%
)
Bitcoin
75,211.83
(
1.83%
)
News Focus
News Focus
Post# of 257428
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122877
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ronpopeil post# 238221

Wednesday, 06/02/2021 10:00:18 AM

Wednesday, June 02, 2021 10:00:18 AM

Post# of 257428
MOR acquires CNST for $34/sh cash—a 68% premium to yesterday’s close—in deal valued at $1.7B:

https://finance.yahoo.com/news/morphosys-acquire-constellation-pharmaceuticals-112500240.html

Concurrently, MOR inked a multifaceted financing deal with Royalty Pharma (RPRX): https://finance.yahoo.com/news/morphosys-acquire-constellation-pharmaceuticals-112500240.html .

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today